Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans
- 1 March 1999
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 33 (3), 464-470
- https://doi.org/10.1016/s0272-6386(99)70183-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- US Adverse Drug Reaction Surveillance 1989-1994Pharmacoepidemiology and Drug Safety, 1996
- A randomized controlled study of iron supplementation in patients treated with erythropoietinKidney International, 1996
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- 'Oversaturation' of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAmerican Journal of Kidney Diseases, 1995
- Serious adverse reactions after intravenous ferric gluconateNephrology Dialysis Transplantation, 1992
- Adverse-Drug-Reaction MonitoringNew England Journal of Medicine, 1986
- Anaphylactoid Reactions in Connection with Infusion of Invert Sugar Solutions are Due to Macromolecular ContaminantsInternational Archives of Allergy and Immunology, 1976